TESLASCAN Drug Patent Profile
✉ Email this page to a colleague
When do Teslascan patents expire, and when can generic versions of Teslascan launch?
Teslascan is a drug marketed by Ic Targets and is included in one NDA.
The generic ingredient in TESLASCAN is mangafodipir trisodium. Additional details are available on the mangafodipir trisodium profile page.
Summary for TESLASCAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 1 |
DailyMed Link: | TESLASCAN at DailyMed |
Recent Clinical Trials for TESLASCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Egetis Therapeutics | Phase 2 |
PledPharma AB | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TESLASCAN
US Patents and Regulatory Information for TESLASCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TESLASCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ic Targets | TESLASCAN | mangafodipir trisodium | INJECTABLE;INJECTION | 020652-001 | Nov 26, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TESLASCAN
See the table below for patents covering TESLASCAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 89794 | ⤷ Sign Up | |
France | 2539996 | AGENT DE DIAGNOSTIC, PROCEDE POUR PREPARER CET AGENT, ET SELS COMPLEXES | ⤷ Sign Up |
Australia | 607456 | ⤷ Sign Up | |
Australia | 8633082 | ⤷ Sign Up | |
United Kingdom | 2137612 | ⤷ Sign Up | |
Argentina | 246956 | COMPUESTO QUELANTE, UN INTERMEDIARIO PARA PREPARAR EL MISMO, Y UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION DE MEDIO DE CONTRASTE. (DIPYRIDOXYL PHOSPHATE NUCLEAR MAGNETIC RESONANCE IMAGERY CONTRAST AGENTS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TESLASCAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0290047 | 97C0108 | Belgium | ⤷ Sign Up | PRODUCT NAME: MANGAFODIPIR TRISODIUM (ANHYDROUS) CORRESP. MANGAFODIPIR; REGISTRATION NO/DATE: EU/1/97/040/001 19970522 |
0071564 | SPC/GB93/060 | United Kingdom | ⤷ Sign Up | |
0290047 | SPC/GB97/078 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
0290047 | 67/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: MANGAFODIPIR; REGISTRATION NO/DATE: SG(97)D/3940 19970522 |
0290047 | C00290047/01 | Switzerland | ⤷ Sign Up | FORMER REPRESENTANTIVE: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAELTE, CH |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |